What is InvaPharm?
InvaPharm operates as a premier contract manufacturer, delivering comprehensive solutions for the dietary supplement, vitamin, and nutritional product markets. With a legacy spanning over six decades, the company provides an end-to-end service model that encompasses product formulation, precision manufacturing, and sophisticated packaging. By maintaining state-of-the-art facilities and adhering to rigorous regulatory standards, InvaPharm serves as a vital partner for brands seeking to scale their operations without compromising on quality or compliance. Their expertise in pilot runs and full-scale production allows them to mitigate risks for clients, ensuring that nutritional brands can effectively meet consumer demand in a highly competitive landscape.
How much funding has InvaPharm raised?
InvaPharm has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in InvaPharm
PPP
Public-Private Partnership
What's next for InvaPharm?
Looking ahead, the recent capital allocation is expected to catalyze InvaPharm's strategic initiatives, particularly in the realms of facility modernization and capacity optimization. As the company transitions through this late-stage growth phase, the focus will likely shift toward integrating advanced automation technologies to enhance throughput and maintain its competitive edge in regulatory adherence. By leveraging this financial momentum, InvaPharm is well-positioned to capture additional market share, potentially expanding its service portfolio to address emerging trends in personalized nutrition and specialized dietary formulations. The firm remains committed to its core mission of providing stress-free, high-quality manufacturing solutions, ensuring long-term value creation for its stakeholders and client base.
See full InvaPharm company page
